en

PRODUCT DETAIL

ELZONRIS 1 mg/ml koncentrát na infúzny roztok

Code 6496D
MA number EU/1/20/1504/001
Product Form: con inf 1x1 ml/1 mg (liek.inj.skl.)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX67 Tagraxofusp
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 07.01.2021
Validity: 07.01.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.11.2022
eu-flag.png sk-flag.png